Hidenori Toyoda Selected Research

Hidenori Toyoda Research Topics

Disease

147	Hepatocellular Carcinoma (Hepatoma) 10/2022 - 03/2002
71	Infections 09/2022 - 11/2002
61	Chronic Hepatitis C 01/2022 - 03/2002
46	Neoplasms (Cancer) 01/2022 - 11/2005
43	Fibrosis (Cirrhosis) 03/2022 - 01/2006
22	Liver Cirrhosis (Hepatic Cirrhosis) 02/2022 - 02/2004
21	Chronic Hepatitis B 01/2022 - 07/2006
19	Liver Diseases (Liver Disease) 01/2022 - 04/2011
14	Hepatitis B 01/2021 - 01/2007
12	Hepatitis C 01/2020 - 04/2008
11	Liver Neoplasms (Liver Cancer) 08/2021 - 08/2005
10	Non-alcoholic Fatty Liver Disease 11/2021 - 02/2013
8	Inflammation (Inflammations) 12/2020 - 02/2004
7	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2004
6	Hepatitis 01/2022 - 07/2006
6	Chronic Hepatitis (Chronic Active Hepatitis) 12/2020 - 04/2007
5	Fatty Liver 01/2022 - 02/2013
5	Hemorrhage 04/2021 - 04/2008
5	Carcinogenesis 12/2020 - 03/2002
4	Disease Progression 01/2022 - 03/2015
4	Virus Diseases (Viral Diseases) 01/2021 - 12/2009
4	Anemia 05/2019 - 02/2014
4	Chronic Renal Insufficiency 02/2019 - 01/2018
4	Hemophilia A (Haemophilia) 03/2012 - 06/2004
3	Diabetes Mellitus 10/2022 - 01/2020
3	Fatigue 06/2022 - 01/2022
3	Ascites 05/2022 - 12/2012
3	Alcoholic Fatty Liver 01/2021 - 01/2012
3	Viremia 01/2021 - 01/2007
3	Persistent Infection 12/2020 - 01/2014

Drug/Important Bio-Agent (IBA)

53	Antiviral Agents (Antivirals)IBA 03/2022 - 11/2007
36	InterferonsIBA 01/2022 - 03/2002
27	Ribavirin (Virazole)FDA LinkGeneric 05/2019 - 03/2005
26	lenvatinibIBA 06/2022 - 01/2019
25	AlbuminsIBA 02/2022 - 01/2016
23	BilirubinIBA 01/2022 - 03/2009
21	Biomarkers (Surrogate Marker)IBA 07/2022 - 12/2006
18	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2022 - 08/2005
14	Tumor Biomarkers (Tumor Markers)IBA 01/2022 - 01/2006
14	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022 - 01/2007
13	Proteins (Proteins, Gene)FDA Link 05/2022 - 11/2011
12	RNA (Ribonucleic Acid)IBA 12/2020 - 03/2002
12	lentil lectinIBA 08/2020 - 08/2005
10	Alanine Transaminase (SGPT)IBA 01/2021 - 03/2002
10	Fetal Proteins (Fetoprotein)IBA 01/2021 - 09/2007
9	AntigensIBA 01/2022 - 01/2016
9	acarboxyprothrombin (PIVKA)IBA 01/2022 - 09/2007
9	MicroRNAs (MicroRNA)IBA 12/2020 - 05/2010
8	atezolizumabIBA 10/2022 - 01/2022
8	Bevacizumab (Avastin)FDA Link 10/2022 - 01/2022
8	GadoliniumIBA 07/2022 - 07/2011
8	Pentetic Acid (DTPA)FDA LinkGeneric 07/2022 - 07/2011
8	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 06/2004
8	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2017 - 06/2007
7	SofosbuvirIBA 03/2022 - 11/2014
7	gadolinium ethoxybenzyl DTPA FDA Link 01/2021 - 07/2011
6	Aspartate Aminotransferases (Aspartate Transaminase)IBA 02/2022 - 01/2015
6	Sorafenib (BAY 43-9006)FDA Link 08/2021 - 04/2013
6	glecaprevir and pibrentasvirIBA 05/2020 - 01/2018
5	entecavir FDA Link 12/2021 - 07/2018
5	Indicators and Reagents (Reagents)IBA 02/2020 - 09/2015
5	Branched-Chain Amino AcidsIBA 01/2020 - 03/2014
5	asunaprevirIBA 08/2019 - 07/2016
5	daclatasvirIBA 08/2019 - 07/2016
5	paritaprevirIBA 04/2019 - 10/2015
5	Ritonavir (Norvir)FDA Link 04/2019 - 10/2015
5	ombitasvirIBA 04/2019 - 10/2015
4	Immune Checkpoint InhibitorsIBA 02/2022 - 06/2020
4	Transaminases (Aminotransferases)IBA 02/2022 - 01/2015
4	Hepatitis B e AntigensIBA 01/2022 - 11/2018
4	Serum AlbuminIBA 01/2022 - 03/2015
4	tenofovir alafenamideIBA 12/2021 - 01/2021
4	Hyaluronic Acid (Hyaluronan)IBA 01/2021 - 12/2012
4	Tyrosine (L-Tyrosine)FDA Link 01/2020 - 09/2015
4	telaprevirIBA 04/2015 - 01/2014
3	C-Reactive ProteinIBA 10/2022 - 01/2022
3	velpatasvirIBA 03/2022 - 07/2018
3	Keratin-18 (Keratin 18)IBA 11/2021 - 01/2017
3	ledipasvirIBA 03/2021 - 06/2015
3	Tenofovir (Viread)FDA Link 01/2021 - 07/2018
3	pibrentasvirIBA 08/2020 - 01/2018
3	glecaprevirIBA 08/2020 - 01/2018
3	Pharmaceutical PreparationsIBA 07/2020 - 10/2015
3	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2019
3	telomerase RNA (bTR)IBA 01/2020 - 09/2015
3	grazoprevirIBA 02/2019 - 04/2017
3	elbasvirIBA 02/2019 - 04/2017
3	perfluorobutane (AI 700)IBA 11/2016 - 09/2014
3	NucleotidesIBA 06/2015 - 01/2008
3	Blood Coagulation Factors (Coagulation Factor)IBA 03/2012 - 03/2005
3	Lamivudine (Epivir)FDA Link 04/2010 - 04/2007
3	HSP27 Heat-Shock ProteinsIBA 07/2008 - 11/2005

Therapy/Procedure

95	Therapeutics 09/2022 - 03/2002
5	Aftercare (After-Treatment) 01/2022 - 12/2012
5	Liver Transplantation 08/2020 - 01/2014
5	Renal Dialysis (Hemodialysis) 02/2019 - 07/2016
5	Hepatectomy 01/2016 - 08/2008
4	Duration of Therapy 08/2020 - 01/2009
4	Drug Therapy (Chemotherapy) 01/2020 - 05/2004
4	Radiofrequency Ablation 02/2018 - 12/2012